Home > Insider Trading > Biolase Inc

Biolase Inc (BIOL)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 15

BIOLASE Inc (BIOL): How It Stacks Up Against Its Peers

Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required...

Keep Reading →

December 13th, 2016 - Hedge Funds News

Birchview Capital's Top Healthcare Stock Picks

Birchview Capital is a Vermont-based biosciences-focused long/short equity hedge fund founded by Dr. Matthew Strobeck in 2014. Dr. Strobeck holds a Ph.D.

Keep Reading →

May 15th, 2016 - Hedge Funds News

Larry N Feinberg, Oracle Associates Open Activist Position in BIOLASE

Larry N Feinberg, the manager of Oracle Associates, has opened a position in BIOLASE Inc (NASDAQ:BIOL). In a recent filing with the Securities and Exchange Commission, Mr.

Keep Reading →

November 25th, 2013 - Hedge Funds News

BIOLASE Inc (BIOL) Shareholders: Have You Seen This Crucial Data?

BIOLASE Inc (NASDAQ:BIOL) was in 4 hedge funds' portfolio at the end of the fourth quarter of 2012. BIOL shareholders have witnessed a decrease in enthusiasm from smart money in recent months.

Keep Reading →

April 29th, 2013 - News

Galena Biopharma Inc (GALE), BIOLASE Inc (BIOL), Achillion Pharmaceuticals, Inc. (ACHN): Three Biotech Giants to Look For

In the world of biotech investing, there are many companies to choose from. When the market is on a riding stride, investment in more speculative stocks that have inflated valuations can get tough.

Keep Reading →

April 3rd, 2013 - News